Oracle Health Sciences Reimagines Clinical Development Technology with New Cloud-Based eClinical Environment of the Future

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. MU
9. IBM
10. HOOD

Go back to Oracle Health Sciences Reimagines Clinical Development Technology with New Cloud-Based eClinical Environment of the Future

Jefferies Reiterates Buy on Oracle (ORCL) Ahead of 4Q Release

June 20, 2017 7:20 AM EDT

Jefferies reiterated a Buy rating and $52.00 price target on Oracle (NYSE: ORCL) ahead of the company's 4Q earnings report.

Analyst John DiFucci expects ORCL's 4Q to be driven by continued strength in Cloud signings and less moderation of the on premise... More